sradovich on DSK3TPTVN1PROD with NOTICES

39678 Federal Register / Vol. 81, No. 117 / Friday, June 17, 2016 / Notices 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Designation of a Class of Employees 

for Addition to the Special Exposure 

Cohort 

AGENCY: National Institute for 

Occupational Safety and Health 

(NIOSH), Centers for Disease Control 

and Prevention, Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: HHS gives notice of a 

decision to designate a class of 

employees from the Argonne National 

Laboratory-West site in Scoville, Idaho, 

as an addition to the Special Exposure 

Cohort (SEC) under the Energy 

Employees Occupational Illness 

Compensation Program Act of 2000. 

FOR FURTHER INFORMATION CONTACT: 

Stuart L. Hinnefeld, Director, Division 

of Compensation Analysis and Support, 

NIOSH, 1090 Tusculum Avenue, MS C– 

46, Cincinnati, OH 45226–1938, 

Telephone 1–877–222–7570. 

Information requests can also be 

submitted by email to DCAS@CDC.GOV. 

SUPPLEMENTARY INFORMATION: 

Authority: 42 U.S.C. 7384q(b). 42 U.S.C. 

7384l(14)(C). 

On June 3, 2016, as provided for 

under 42 U.S.C. 7384l(14)(C), the 

Secretary of HHS designated the 

following class of employees as an 

addition to the SEC: 

All employees of the Department of 

Energy, its predecessor agencies, and their 

contractors and subcontractors who worked 

at the Argonne National Laboratory-West 

during the time period from April 10, 1951, 

through December 31, 1957, for a number of 

work days aggregating at least 250 work days, 

occurring either solely under this 

employment, or in combination with work 

days within the parameters established for 

one or more other classes of employees in the 

Special Exposure Cohort. 

This designation will become 

effective on July 3, 2016, unless 

Congress provides otherwise prior to the 

effective date. After this effective date, 

HHS will publish a notice in the 

Federal Register reporting the addition 

of this class to the SEC or the result of 

any provision by Congress regarding the 

decision by HHS to add the class to the 

SEC. 

John Howard, 

Director, National Institute for Occupational 

Safety and Health. 

[FR Doc. 2016–14328 Filed 6–16–16; 8:45 am] 

BILLING CODE 4163–19–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Request for Public Comments on the 

Development of the IACC Strategic 

Plan for Autism Spectrum Disorder 

(ASD) 

SUMMARY: On behalf of the Interagency 

Autism Coordinating Committee (IACC) 

(http://www.iacc.hhs.gov/), the National 

Institute of Mental Health (NIMH) Office 

of Autism Research Coordination 

(OARC) is seeking public comments to 

assist the IACC in identifying priorities 

for the 2016 update of the IACC 

Strategic Plan for Autism Spectrum 

Disorder (ASD) (current IACC Strategic 

Plan can be viewed at https:// 

iacc.hhs.gov/publications/strategicplan/2013/) as required by the Autism 

Collaboration, Accountability, Research, 

Education and Support (CARES) Act of 

2014 (Pub. L. 113–157). 

The IACC is requesting public 

comments on research, services, and 

policy issues related to the seven topics 

addressed by the IACC Strategic Plan: 

Screening and Diagnosis, Underlying 

Biology of ASD, Risk Factors, 

Treatments and Interventions, Services, 

Lifespan Issues, and Surveillance and 

Infrastructure. 

DATES: Responses to this notice are 

voluntary and the public comment 

period will be open from June 15, 2016– 

July 29, 2016. 

ADDRESSES: All comments must be 

submitted electronically via the webbased form at: https://iacc.hhs.gov/ 

meetings/public-comments/requests-forinformation/2016/strategic-plan.shtml. 

FOR FURTHER INFORMATION CONTACT: 

Specific questions about this Request for 

Public Comment should be directed to: 

IACCRFI@mail.nih.gov. 

SUPPLEMENTARY INFORMATION: The IACC, 

a federal advisory committee composed 

of federal and public members, was 

established under the Combating 

Autism Act of 2006. The Committee was 

most recently reauthorized under the 

Autism CARES Act of 2014. The law 

requires that the IACC develop a 

strategic plan for autism research and 

update the Plan annually. The IACC last 

provided an update on the progress of 

the Strategic Plan in 2013. The IACC 

Strategic Plan is organized around seven 

questions that are important for people 

with ASD and their families: 

1. When should I be concerned? 

(Screening and Diagnosis) 

2. How can I understand what is 

happening? (Underlying Biology of 

ASD) 

3. What caused this to happen and 

can this be prevented? (Risk Factors) 

4. Which treatments and interventions 

will help? (Treatments and 

Interventions) 

5. Where can I turn for services? 

(Services) 

6. What does the future hold, 

especially for adults? (Lifespan Issues) 

7. What other infrastructure and 

surveillance needs must be met? 

(Surveillance and Infrastructure) 

Submission Information. For each 

chapter of the IACC Strategic Plan, 

commenters may provide input on what 

they consider to be the most important 

research, services and policy issues and 

remaining gaps in the subject area 

covered by that chapter. Please note that 

the web form will accept a maximum of 

1,500 characters (including letters, 

numbers, punctuation, etc.) per topic 

area. A valid email address is required 

for submission, and only one 

submission per email address will be 

accepted. If duplicate submissions are 

received, only one example of such a 

submission will be included in the final 

set of comments. 

The information that commenters 

provide will become part of the public 

record; as such, please do not include 

any personally identifiable or 

confidential information in the 

comments. The web form will provide 

the option of submitting responses 

anonymously, or the choice to include 

a name and/or organization associated 

with the comment. Comments are 

subject to redaction in accordance with 

federal policies. All comments or 

summaries of comments received will 

be made publicly available on the IACC 

Web site (www.iacc.hhs.gov) within 90 

days of the closing deadline for this 

notice. Email addresses associated with 

comments will not be included as part 

of the public disclosure. After the 

closing deadline, responses cannot be 

edited or withdrawn. No basis for 

claims against the U.S. Government 

shall arise as a result of a response to 

this request for information or from the 

Government’s use of such information. 

Instructions. All comments must be 

submitted through the Web form at 

https://iacc.hhs.gov/meetings/publiccomments/requests-for-information/ 

2016/strategic-plan.shtml. Individuals 

submitting comments will receive an 

onscreen confirmation acknowledging 

receipt of the comment, but commenters 

will not receive individualized feedback 

or responses from the IACC. Only one 

comment per email address will be 

accepted, and if duplicate comments are 

received, only one example will be 

provided to the IACC. For further 

submission details and requirements